© 2023 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Autoimmune Diseases
FDA Update: Merck Action on Keytruda Gastric Cancer Indication Tops Busy Week
July 03, 2021
Merck will withdraw Keytruda's advanced gastric indication after an FDA panel vote, a drug with supply problems gets a new indication, NDAs for an HIV therapy, and other news.
NORD Report: COVID-19 Telehealth Surge Especially Important for People With Rare Diseases
November 12, 2020
Telehealth during the COVID-19 pandemic has been especially important to patients with rare disorders, many of which are autoimmune diseases, according to a recent report from the National Organization for Rare Disorders.
New Data Show How Anifrolumab Could Offer Improvement in Lupus, SLE
November 09, 2020
New data presented recently at the American College of Rheumatology meeting add to the evidence in support of anifrolumab, which could address unmet need in lupus.
Time to Revise Hydroxychloroquine, Retinopathy Guidelines, Say Authors
October 21, 2020
Rather than stopping hydroxychloroquine altogether, doses could be reduced and patients monitored if there are signs of retinopathy, say the authors of a commentary in the American Journal of Ophthalmology.
Obesity Linked to Inflammation, Disease Severity Among People With Ankylosing Spondylitis
October 10, 2020
Central obesity may be especially unhealthy for people with the inflammatory condition that affects the spine.
The Difference Gender Makes in Psoriatic Arthritis
October 10, 2020
Research documents that the disease affects men and women differently.
FDA Updates: Opdivo Plus Yervoy for MPM, Pediatric Indications for Simponi Aria, Breakthrough Designation in CKD
October 04, 2020
An immunotherapy combination gets a third thoracic indication; another potential indication for an SGLT2 inhibitor.
For Autoimmune Disease Patients, Fatigue Isn't Just Another Word for Being Tired
September 13, 2020
Fatigue causes a complex array of problems for people with autoimmune disease.
Severity of Skin Symptoms Key Factor in the Quality of Life of People with Psoriatic Arthritis
September 08, 2020
Study of the quality of life of psoriatic arthritis patients reveals the added burden of skin symptoms.
FDA Updates: Ofatumumab for MS, More Data Needed for Filgotinib in RA, Hearing Set for ALKS 3831
August 23, 2020
FDA actions for the week ending August 21, 2020, include a hearing set for a drug that could limit weight gain often associated with treatment for serious mental illness.